Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORAL7® vs Chlorhexidine Mouthwash After Wisdom Tooth Surgery
NCT07627945Completed
- Sponsor
- MBD Marketing
- Start
- Oct 2025
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
Randomised, single-blind trial of ORAL7 Mouthwash in postoperative pain, trismus and wound healing (2 arms), sponsored by MBD Marketing. Primary endpoints: Postoperative Pain at 7 days, Landry Wound Healing Index at 7 days and 1 more. Started Oct 2025; status: completed.
02
Drugs
ORAL7 Mouthwash
03
Conditions
postoperative paintrismuswound healing
Beyond the preview
Go deeper on NCT07627945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07627945.